enVVeno Medical Corporation (5HJ.F)
enVVeno Medical Corporation
70 Doppler
Irvine, CA 92618
United States
949 261 2900
https://www.envveno.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 24
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Robert A. Berman | CEO & Director | 665.65k | N/A | 1963 |
| Mr. Craig Thomas Glynn | CFO, Treasurer & Sec. | 250.65k | N/A | 1961 |
| Dr. Marc H. Glickman M.D. | Sr. VP & Chief Medical Officer | 456.95k | N/A | 1949 |
| Mr. Warren Hancock | Co-founder | N/A | N/A | N/A |
| Dr. Hamed Alavi Ph.D. | Sr. VP & Chief Technology Officer | N/A | N/A | N/A |
| Dr. Benedict Broennimann M.D. | Chief Medical Officer of Outside of United States | N/A | N/A | 1957 |
Description
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Corporate Governance
enVVeno Medical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
